Review Article
Transitioning to Pegylated Interferon for the Treatment of Cutaneous T-Cell Lymphoma: Meeting the Challenge of Therapy Discontinuation and a Proposed Algorithm
Table 3
Prior therapies to interferon that were trialed in the presented cohort of patients.
| ||||||||||||||||||||||||||||||||||||
Patients who received interferon before the course in which they were switched to pegylated interferon. TCS, topical corticosteroids; ECP, extracorporeal photopheresis; PUVA, psoralen + UVA; TSEB, total skin electron beam therapy; IFN, interferon. |